# Incomplete Follow-Up and Competing Risks as Sources of Bias in Vascular Surgical Investigations

**Authors:** Andrej Udelnow, Semion Smorodin, Efim Sinicin, Joerg Tautenhahn, Joerg Herold, Udo Barth, Zuhir Halloul

PMC · DOI: 10.3390/jcm14207419 · Journal of Clinical Medicine · 2025-10-21

## TL;DR

This study shows that incomplete follow-up and competing risks can bias outcomes in vascular surgery research, especially for patients with advanced peripheral artery disease.

## Contribution

The study introduces the follow-up index (FUI) to quantify incomplete follow-up and demonstrates its impact on outcome bias in PAD patients.

## Key findings

- Incomplete follow-up is linked to advanced PAD and may hide worse clinical outcomes.
- CLTI and FUI are significant predictors of reintervention-free and amputation-free survival.
- Competing risks like amputation and death should be considered to avoid biased conclusions.

## Abstract

Background/Objectives: The aim of this study was to determine whether incomplete follow-up and competing event risks may be associated with the clinical course after treatment and with known risk factors, such as chronic limb-threatening ischemia (CLTI), in peripheral artery disease (PAD) patients. Methods: Patients hospitalized with PAD who were treated by endovascular or open-surgical means and followed up were included in this retrospective observational study. The primary outcome was reintervention-free survival (RFS); the secondary outcomes and competing events were major amputation and death. The follow-up index (FUI), defined as the ratio between the real and the maximal follow-up interval, was determined for each patient. Results: The FUI depended significantly on the disease stage of CLTI (estimate: −0.16; p: 0.003), endovascular (0.17; p: 0.007) or open-surgical intervention (0.21; p: 0.007) and intra-hospital re-operation (−0.29; p: 0.002) and tended to decrease with age (−0.004; p: 0.09). Independent of disease stage, patients with claudication or CLTI with an FUI < 0.5 had shorter RFS than patients with a FUI ≥ 0.5 (Cox regression, p: 0.07; log-rank test, p: 0.03). When both the FUI and competing risks were considered using Fine–Gray regression analysis, CLTI was associated with RFS (p: 0.016), while FUI (p: 0.004), CLTI (p < 0.001), and the involvement of common femoral (p < 0.001) and posterior tibial arteries (p < 0.001) were associated with major amputation-free survival. Conclusions: Incomplete follow-up is associated with advanced PAD and may itself mask a worse outcome, such as reintervention, restenosis, major amputation, or death. Competing events should also be considered potential sources of bias. Therefore, the FUI and competing events should be reported, and conclusions should be drawn cautiously in both observational and randomized prospective clinical studies.

## Full-text entities

- **Diseases:** claudication (MESH:D007383), restenosis (MESH:D023903), CLTI (MESH:D000089802), death (MESH:D003643), PAD (MESH:D058729)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12565133/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12565133/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12565133/full.md

---
Source: https://tomesphere.com/paper/PMC12565133